Log in
NASDAQ:EXPO

Exponent Stock Forecast, Price & News

$69.59
-2.02 (-2.82 %)
(As of 10/30/2020 12:00 AM ET)
Add
Compare
Today's Range
$68.42
Now: $69.59
$74.27
50-Day Range
$70.74
MA: $73.76
$77.32
52-Week Range
$58.03
Now: $69.59
$84.62
Volume717,205 shs
Average Volume278,781 shs
Market Capitalization$3.59 billion
P/E Ratio45.78
Dividend Yield1.06%
Beta0.25
Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company worldwide. Its services include analysis of product development, product recall, regulatory compliance, and the discovery of potential problems related to products, people, property, and impending litigation. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, electrical engineering and computer science, human factors, industrial structures, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, statistical and data sciences, thermal sciences, and vehicle analysis. The Environmental and Health segment offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. The company offers approximately 90 different technical disciplines to solve complicated issues facing industry and government. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors of the economy. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. Exponent, Inc. was founded in 1967 and is headquartered in Menlo Park, California.
Read More
Exponent logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.4Dividend Strength: 1.7Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.84 out of 5 stars

Industry, Sector and Symbol

Industry Management consulting services
Sub-IndustryResearch & Consulting Services
Current SymbolNASDAQ:EXPO
CUSIP30214U10
Phone650-326-9400
Employees1,201

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$417.20 million
Cash Flow$1.63 per share
Book Value$6.76 per share

Profitability

Net Income$82.46 million

Miscellaneous

Market Cap$3.59 billion
Next Earnings Date2/4/2021 (Estimated)
OptionableOptionable
$69.59
-2.02 (-2.82 %)
(As of 10/30/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive EXPO News and Ratings via Email

Sign-up to receive the latest news and ratings for EXPO and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Exponent (NASDAQ:EXPO) Frequently Asked Questions

How has Exponent's stock price been impacted by COVID-19?

Exponent's stock was trading at $75.99 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, EXPO shares have decreased by 8.4% and is now trading at $69.59.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Exponent?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Exponent in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Exponent
.

When is Exponent's next earnings date?

Exponent is scheduled to release its next quarterly earnings announcement on Thursday, February 4th 2021.
View our earnings forecast for Exponent
.

How were Exponent's earnings last quarter?

Exponent, Inc. (NASDAQ:EXPO) posted its earnings results on Thursday, October, 29th. The business services provider reported $0.34 EPS for the quarter, topping the Zacks' consensus estimate of $0.27 by $0.07. The business services provider earned $98.70 million during the quarter, compared to analysts' expectations of $91.73 million. Exponent had a net margin of 19.87% and a return on equity of 23.87%. Exponent's quarterly revenue was down 2.8% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.36 earnings per share.
View Exponent's earnings history
.

How often does Exponent pay dividends? What is the dividend yield for Exponent?

Exponent declared a quarterly dividend on Monday, August 3rd. Stockholders of record on Friday, September 11th will be given a dividend of $0.19 per share on Friday, September 25th. This represents a $0.76 annualized dividend and a dividend yield of 1.09%. The ex-dividend date is Thursday, September 10th.
View Exponent's dividend history
.

When did Exponent's stock split? How did Exponent's stock split work?

Shares of Exponent split before market open on Thursday, June 7th 2018. The 2-1 split was announced on Tuesday, May 15th 2018. The newly created shares were issued to shareholders after the closing bell on Wednesday, June 6th 2018. An investor that had 100 shares of Exponent stock prior to the split would have 200 shares after the split.

What price target have analysts set for EXPO?

2 brokerages have issued 12-month target prices for Exponent's stock. Their forecasts range from $84.00 to $94.00. On average, they anticipate Exponent's stock price to reach $89.00 in the next year. This suggests a possible upside of 27.9% from the stock's current price.
View analysts' price targets for Exponent
.

Are investors shorting Exponent?

Exponent saw a increase in short interest during the month of September. As of September 30th, there was short interest totaling 1,300,000 shares, an increase of 45.2% from the September 15th total of 895,500 shares. Based on an average trading volume of 248,400 shares, the short-interest ratio is presently 5.2 days. Approximately 2.6% of the shares of the company are short sold.
View Exponent's Short Interest
.

Who are some of Exponent's key competitors?

What other stocks do shareholders of Exponent own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Exponent investors own include AbbVie (ABBV), Pfizer (PFE), Abbott Laboratories (ABT), Energy Transfer (ET), Ford Motor (F), Micron Technology (MU), AT&T (T), UnitedHealth Group (UNH), Visa (V) and Adobe (ADBE).

Who are Exponent's key executives?

Exponent's management team includes the following people:
  • Dr. Paul R. Johnston, Exec. Chairman (Age 66, Pay $72.92k)
  • Dr. Catherine Ford Corrigan, Pres, CEO & Director (Age 51, Pay $1.35M)
  • Mr. Richard L. Schlenker Jr., Exec. VP, CFO & Corp. Sec. (Age 54, Pay $989.94k)
  • Ms. Sally B. Shepard, Chief HR Officer (Age 59, Pay $658.6k)
  • Dr. Harri K. Kytomaa, Group VP and Principal Engineer Mechanical & Thermal (Age 61, Pay $715.82k)
  • Dr. Steven J. Murray, Group VP & Principal Engineer (Age 45, Pay $781.32k)
  • Dr. Bernard Ross, Co-Founder, Chairman Emeritus & Principal Engineer
  • Dr. Subbaiah V. Malladi, CTO & Principal Engineer (Age 73)
  • Mr. Eric R. Anderson, VP & Corp. Controller
  • Dr. Robert D. Caligiuri, Corp. VP of Materials & Corrosion Engineering and Principal Engineer (Age 68)

What is Exponent's stock symbol?

Exponent trades on the NASDAQ under the ticker symbol "EXPO."

Who are Exponent's major shareholders?

Exponent's stock is owned by many different retail and institutional investors. Top institutional investors include Conestoga Capital Advisors LLC (3.68%), Riverbridge Partners LLC (1.81%), Copeland Capital Management LLC (0.78%), Envestnet Asset Management Inc. (0.44%), Comerica Bank (0.33%) and WINTON GROUP Ltd (0.11%). Company insiders that own Exponent stock include Bradley A James, Carol Lindstrom, Harri Kytomaa, John Pye, Maureen T F Reitman, Paul R Johnston, Richard L Schlenker Jr, Richard Reiss, Sally Shepard and Steven J Murray.
View institutional ownership trends for Exponent
.

Which major investors are selling Exponent stock?

EXPO stock was sold by a variety of institutional investors in the last quarter, including WINTON GROUP Ltd, Copeland Capital Management LLC, Robeco Institutional Asset Management B.V., Cordasco Financial Network, CWM LLC, Diversified Trust Co, State of Alaska Department of Revenue, and Amalgamated Bank. Company insiders that have sold Exponent company stock in the last year include Bradley A James, Carol Lindstrom, Harri Kytomaa, Maureen T F Reitman, Paul R Johnston, Richard L Schlenker Jr, Richard Reiss, Sally Shepard, and Steven J Murray.
View insider buying and selling activity for Exponent
.

Which major investors are buying Exponent stock?

EXPO stock was bought by a variety of institutional investors in the last quarter, including Conestoga Capital Advisors LLC, Assenagon Asset Management S.A., Comerica Bank, Riverbridge Partners LLC, Envestnet Asset Management Inc., Vestmark Advisory Solutions Inc., Louisiana State Employees Retirement System, and BNP Paribas Arbitrage SA.
View insider buying and selling activity for Exponent
.

How do I buy shares of Exponent?

Shares of EXPO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Exponent's stock price today?

One share of EXPO stock can currently be purchased for approximately $69.59.

How big of a company is Exponent?

Exponent has a market capitalization of $3.59 billion and generates $417.20 million in revenue each year. The business services provider earns $82.46 million in net income (profit) each year or $1.53 on an earnings per share basis. Exponent employs 1,201 workers across the globe.

What is Exponent's official website?

The official website for Exponent is www.exponent.com.

How can I contact Exponent?

Exponent's mailing address is 149 COMMONWEALTH DRIVE, MENLO PARK CA, 94025. The business services provider can be reached via phone at 650-326-9400 or via email at [email protected]

This page was last updated on 10/31/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.